Our mission is to provide quality medicines that are affordable and available across Africa.
We are proud of our rich history that started more than thirty years ago in Central Africa.
Read about Shalina Healthcare’s recent articles on various health topics.
Our quality assurance and quality control systems ensure strict compliance to required standards
Our dedicated registrations team maintains pace with dynamic regulatory guidelines
We provide medicines from our own manufacturing facility and from long-term qualified partners.
Sunat A is a therapy indicated for the treatment of all forms of malaria, including multi drug-resistant strains
Treatment of uncomplicated P. falciparum malaria.
Artesunate: Artemisinin derivative. Amodiaquine: 4-amino quinoline derivative.
Agranulocytosis and other blood dyscrasias, hepatitis and peripheral neuropathy have been reported occasionally after Amodiaquine usage alone. Administration of quinolin...
Known hypersensitivity to Amodiaquine or 4 - amino quinolines and Artesunate or Artemisinin derivatives. Because of resistance and risk of major toxicity, Amodiaquine is not recommended for the prophylaxis of malaria. Amodiaquine is also contraindicated in patients with hepatic disorders.>
About Shalina Healthcare
Shalina Healthcare is a market leader in making quality healthcare products affordable and available across Africa.
We achieve this by sourcing from WHO-approved production facilities in India and China and by focusing on our first-class distribution expertise.
Useful Links
Challenges & Featured
Get in touch
30th Floor, Almas Tower, Jumeirah Lakes Towers, Dubai, UAE.
P.O. Box 340575, Dubai, UAE.
Tel: +971 4 430 9111
Fax: +971 4 430 9112
© 2023 Shalina Healthcare. All Rights Reserved